Navigate Up
Sign In

Skip Navigation LinksHome > Τμήμα Ιατρικής > Διδακτικό Ερευνητικό Προσωπικό

Διδακτικό Ερευνητικό Προσωπικό

expand  Βαθμίδα: Καθηγητής
Ανθρακόπουλος Μιχαήλ
Αποστολόπουλος Δημήτριος
Βανταράκης Απόστολος
Βογιατζής Γρηγόριος
Γεωργίου Σοφία
Γκρέκα-Σπηλιώτη Βασιλική
Γουρζής Φίλιππος
Γώγος Χαράλαμπος
Δεκαβάλας Γεώργιος
Δραΐνας Διονύσιος
Ζολώτα Βασιλική
Καλόφωνος Χαράλαμπος
Καρναμπατίδης Δημήτριος
Κυπραίος Κυριάκος
Κωσταρίδου Ελένη
Λιάτσικος Ευάγγελος
Λυγερού Ζωή
Μάρκου Κωνσταντίνος
Μελαχροινού Μαρία
Μοσχονάς Νικόλαος
Ναξάκης Στέφανος
Ντίνος Γεώργιος
Παναγιωτάκης Γεώργιος
Παπαδάς Θεόδωρος
Παπαχρήστου Διονύσιος
Πέτρου-Παπαδάκη Ελένη
Σπηλιοπούλου-Σδούγκου Ίρις
Σπυρόπουλος Κωνσταντίνος
Σταράκης Ιωάννης
Ταραβήρας Σταύρος
Τυλλιανάκης Μίνως
Χαμπαίος Ιωάννης
Χριστοφίδου Μυρτώ
Χρύσης Διονύσιος
expand  Βαθμίδα: Αναπληρωτής Καθηγητής
Ασημακοπούλου Μάρθα
Γεωργακόπουλος Κωνσταντίνος
Γκατζούνης Γεώργιος
Γκλιάτης Ιωάνννης
Ελλούλ Ιωάννης
Καγκάδης Γεώργιος
Κάκκος Σταύρος
Καλογεροπούλου Χριστίνα
Καπώνης Απόστολος
Κεχαγιάς Ιωάννης
Κολονίτσιου Φεβρωνία
Κουρέα Ελένη
Κούτρας Άγγελος
Μακατσώρης Θωμάς
Μαρούλης Ιωάννης
Μαστρονικολής Νικόλαος
Μπράβου Βασιλική
Παναγόπουλος Κωνσταντίνος
Πάνος Γεώργιος
Παπαδόπουλος Βασίλειος
Παπαχατζοπούλου Αδαμαντία
Πασματζή Ευσταθία
Πολυχρονόπουλος Παναγιώτης
Σακελλαρόπουλος Γεώργιος
Σκρουμπής Γεώργιος
Σολωμού Αικατερίνη
Σταθόπουλος Γεώργιος
Φλίγκου Φωτεινή
Χειλαδάκης Ιωάννης
expand  Βαθμίδα: ​Επίκουρος Καθηγητής
Ακινοσόγλου Καρολίνα - Ανθούλα
Ανδρουτσόπουλος Γεώργιος
Ασημακόπουλος Στυλιανός
Βουκελάτου Γεωργία
Δαούσης Δημήτριος
Καρατζά Αγγελική
Κατσάνος Κωνσταντίνος
Κωλέτσης Ευστράτιος Νικόλαος
Παναγιωτόπουλος Βασίλειος
Παπαθανασίου Νικόλαος
Παπαχρήστου Ευάγγελος
Σολωμού-Λιόση Έλενα
Σύγγελος Σπύρος
Τριάντος Χρήστος
expand  Βαθμίδα: Λέκτορας
Μιχαήλ Γεώργιος
Δεν υπάρχει φωτογραφία
Γεώργιος Πάνος
Βαθμίδα:Αναπληρωτής Καθηγητής
Τομέας:Παθολογικός Ι
Κλινική/Εργαστήριο:
Κλινική Παθολογίας
Γνωστικό Αντικείμενο:ΠΑΘΟΛΟΓΙΑ-ΛΟΙΜΩΔΗ ΝΟΣΗΜΑΤΑ
Ερευνητικοί Τομείς Ενδιαφέροντος:Λοιμώξεις- Λοιμωξιολογία, Παθολογία, HIV, Ηπατίτιδες, ΤΒ, Τροπική Ιατρική, Κλινική Ιολογία, Νοσοκομειακές Λοιμώξεις, Λοιμώξεις από Πολυανθεκτικά Παθογόνα, Σήψη, Βιοϊατρική Τεχνολογία και Πληροφορική
Διεύθυνση:Πανεπιστημιακό Νοσοκομείο Πατρών, Πανεπιστημιακή Παθολογική Κλινική, Τμήμα Λοιμώξεων, 26504 Ρίο-Πάτρα, Ελλάδα
Γραφείο:2ος Όροφος, Τμήμα Λοιμώξεων
Τηλέφωνο:2610999739
Fax:2610999740
E-mail:
george.panos@upatras.gr
george.panos@med.upatras.gr
Προσωπική Ιστοσελίδα:
http://www.researchgate.net/profile/George_Panos2/
http://www.researchgate.net/profile/George_Panos2/publications/
Σύντομο Βιογραφικό Σημείωμα
 

Περίληψη Βιογραφικού Σημειώματος

GEORGE PANOS
 
POSITION TITLE
Assistant Professor in Internal Medicine & Infectious Diseases,
University of Patras Medical School, Patras University General Hospital, Patras, Achaia, Greece.
BSc (Biomed. Eng.), CEng, MIET, MD, PhD, DTM&H(Lon), FRCP
 
EDUCATION/TRAINING 
INSTITUTION AND LOCATION DEGREE YEAR(s) FIELD OF STUDY
• University of Salford, U.K. BSc 1978 Biomedical Engineering. [Dept. of Electrical & Electronic Engineering]
• University of Athens Medical School, Greece MD 1983 Medicine
• University of Athens Medical School, Greece. PhD 1991 Doctoral Thesis (Medicine)
• London School of Hygiene and Tropical Medicine, U.K. DTM&H(Lon) 1998 Tropical Medicine & Hygiene

Positions and Employment
• 1985-1990 Medical Residency, Specialty in Internal Medicine, 1st Internal Medicine Clinic, University of Athens Medical School, Laikon General Hospital, Athens.
• 1991-1993 Fellow in Infectious Diseases, Research Laboratory and Dept. of Infectious Diseases, 1st Propaedeutic Medicine Clinic, University of Athens Medical School, Laikon General Hospital, Athens.
• 1992 Fellow, Medical Physics, University of Athens Medical School, Athens.
• 1993-1997 Specialist Physician, (Epimelitis B’), 2nd Internal Medicine Clinic and HIV Unit, 1st IKA ‘Penteli’ General Hospital, Athens.
• 1993-1997 Concomitant Private Practice of Medicine as a Specialist Physician, Athens.
• 1997(Feb)-1998(May) Senior Registrar, Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital (Teaching), Birmingham, England, U.K.
• 1998(Jun)-2008(May) Head, HIV Unit, Specialist Physician (Epimelitis A’), 2nd Internal Medicine Clinic, 1st IKA ‘Penteli’ General Hospital, Athens.
• 1998-2007 Concomitant Private Practice of Medicine as a Specialist Physician, Athens.
• 1998(Sep)-2000 & 2002 Temporary lecturer (General Medicine), TEI, School of Medical and Social Security Professions, Athens.
• 2007(April)-2008(April) Research, HIV & GUM Directorate, St. Stephen’s Centre, Chelsea & Westminster Hospital, London, UK.
• 2008(April)-2008(May) Head, HIV Unit, Specialist Physician (Epimelitis A’), 2nd Internal Medicine Clinic, 1st IKA ‘Penteli’ General Hospital, Athens.
• 2008(May) Assistant Professor in Internal Medicine & Infectious Diseases, University of Patras Medical School, Patras University General Hospital, Patras, Achaia, Greece.

Other Experience and Professional Memberships
• 1978-2002 AMIEE, Associate Member, Institution of Electrical Engineers, U.K.
• 1984 Registration General Medical Council (GMC), UK.
• 1992-todate Engineering Council Registration, U.K.
• 2003-todate MIEE, Member, Institution of Electrical Engineers, U.K.
• MIET (IEE renamed IET), Member, Institution of Engineering Technology, UK.
• 2003-todate CEng, Chartered Engineer, Institution of Electrical Engineers, U.K.
• 1998-2000 Steering Committee, The COLATE Trial, a Multicenter European study group on HIV in Europe.
• 1999-todate Editorial Panel, HIV Medicine.
• 2000-2010 Editorial Panel/Scientific Committee, Hellenic Archives of AIDS.
• 2004-2005 Co-ordinator, Epidemiological awareness program on Hospital Level between 1st IKA ‘Penteli’ General Hospital and Hellenic CDC/Office of the Olympic Games and Travel Medicine. Decision Protocol No. 9720.
• 2009, 1st of May, Admission to the Royal College of Physicians, London, as a Fellow of the College [FRCP].
• 2011-todate Editorial Panel, Infectious Diseases International Journal ‘GERMS’.

Membership of Committees
• 1993-1996 & 1998-2001 Member, Nosocomial Infections Committee, 1st IKA ‘Penteli’ General Hospital, Athens.
• 2002-2007 Chair, Nosocomial Infections Committee, 1st IKA ‘Penteli’ General Hospital, Athens.
• 2001-2007 Member, Special Committee on high cost medications and medications without HDA and/or EMEA approval, IKA Administration, Athens.
• 2005-2008 Member, Committee on Antiretroviral therapy, Hellenic CDC, Ministry of Health.
• 2013-Todate, Member, National Committee for the study and implementation of measures to reduce Nosocomial Infections from Resistant Microorganisms in Greek Hospitals.

Accreditations and Medical Practice Diplomas
• Specialty Accreditation in Internal Medicine (Greece)
• Specialty Accreditation in General/Internal Medicine (UK)
• Sub-Specialty Accreditation in Infectious Diseases (Greece)
• Specialty Accreditation in Internal Medicine (Cyprus)
• Specialty Accreditation in Infectious Diseases (Cyprus)
• Diploma in Tropical Medicine and Hygiene, London School of Hygiene and Tropical Medicine, [DTM&H(Lon)], (UK)

Honors
• 1999 Second Prize, 2nd National Congress on AIDS and Sexually Transmitted Diseases, Athens.
• 2000 First Prize, 12th Panhellenic AIDS Congress, Athens.
• 2008 Best Poster, 4th International Workshop on HIV and Hepatitis Co-infection Congress, 19-21 June, Madrid, Spain.

Completed & Ongoing Research
• Have participated and continue to participate in multicenter study groups e.g. Eurosida, DAD, COLATE, EARTH cohort, AMACS (Hellenic cohort), SMART study, double-blind and open-labeled trials as principal investigator such as Tipranavir Phase II/III, Nandrolone Decanoate, TMC214, T20-Enfuvirtide, Atazanavir etc. as well as a number of ART expanded access protocols.
• Currently studying genotype profiles from Greek patients depicting sequential mutations with respect to sequential antiretroviral therapy (pertinent manuscript published).
• Shortly completing medical record database management system with medical report generation depicting and analyzing data of all HIV patients cared for at a special infections unit.
• Have created and installed an HIV/AIDS internet site addressed to patients, medical personnel, the public and, facilitate through secure code, data entry and management of medical parameters, to collaborating HIV units (www.hivaids.gr).
• Involved in the development of a temporal Artificial Intelligence model with an International team to follow viral surrogate markers together with demographics, biochemical and laboratory data to describe the drug-virus-host interactions, and have made some initial validation of models (pertinent manuscript published).
• Carried out research (and have produced abstracts/posters/oral presentation in Congresses and submitted manuscripts for publications in Medical Journals) on Transient Elastography pertaining to: HIV/HCV, HIV/HBV, HIV/HCV/HBV, HCV, HBV, HCV/HBV coinfected patients and cryptogenic hepatopathy/hepatitis. [St. Stephen’s Centre, HIV & GUM Directorate, Chelsea & Westminster Hospital, London, UK.]
• Described a New Clinical Syndrome in Medicine: ‘Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhoticportal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV. Panos G et al. J Acquir Immune Defic Syndr. 2009 Dec 1:52(4):525-7. [St. Stephen’s Centre, HIV & GUM Directorate, Chelsea & Westminster Hospital, London, UK.]
• Written on HIV Entry, Entry Inhibition, with corresponding publications (a number of publications still pending). [St. Stephen’s Centre, HIV & GUM Directorate, Chelsea & Westminster Hospital, London, UK.]
• At The University of Patras School of Medicine, Patras University General Hospital, involved in Internal Medicine & Infectious Diseases caring for inpatients at all Hospital Departments and specialties, and also for outpatients, including patients with Hepatitis A, B, C, HIV and classical Infectious Diseases.
• Produced manuscripts in the above areas including Clinical Virology.
• Formed a research group with Electrical and IT Engineers at the University of Patras working on Applications of IT in Medicine with particular interest in developing a Differential Diagnosis application in Internal Medicine.
• Have written as author or participated in publications as investigator, including in Multicenter International Studies, in over 92 publications listed on Pubmed when entering search ‘panos g’ [as author or investigator].

Προπτυχιακά Μαθήματα

Μεταπτυχιακά Μαθήματα

• ΙΑΤΡΙΚΗ ΧΗΜΕΙΑ
("Αντιρετροϊκά και Κυτταρικοί Τόποι Δράσης")

Επιλεγμένες Δημοσιεύσεις

Δείτε όλες τις Δημοσιεύσεις
Publications as author:
 
For the publications 1-42 below as author-
Citation Index: (SCOPUS)
Total Impact Factor (IF)= 185.556
Average Impact Factor (IF)= 4.418
Citations= 1005
h-index= 18
 
1. Crimean-Congo hemorrhagic fever: seroprevalence and risk factors among humans in Achaia, western Greece, Sargianou M, Panos G, Tsatsaris A, Gogos C, Papa A. Int J Infect Dis. 2013 Sep 10. doi:pii: S1201-9712(13)00259-2. 10.1016/j.ijid.2013.07.015, PMID: 24084247
2. Epidemiology of Hantavirus infections in humans: A comprehensive, global overview, Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G. Crit Rev Microbiol. 2013 Apr 22. , PMID: 23607444
3. Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals, Paraskevis D, Touloumi G, Bakoyannis G, Paparizos V, Lazanas M, Gargalianos P, Chryssos G, Antoniadou A, Psichogiou M, Panos G, Katsarou O, Sambatakou H, Kordossis T, Hatzakis A; AMACS, AIDS Res Hum Retroviruses. 2013 Mar;29(3):461-9. doi: 10.1089/AID.2012.0143. Epub 2012 Nov 6,  PMID: 23034083 [PubMed - indexed for MEDLINE]
4. Red man syndrome adverse reaction following intravenous infusion of cefepime, Panos G, Watson DC, Sargianou M, Kampiotis D, Chra P., Antimicrob Agents Chemother. 2012 Dec;56(12):6387-8. doi: 10.1128/AAC.01274-12. Epub 2012 Sep 4, PMID: 22948884 [PubMed - indexed for MEDLINE] Free PMC Article
5. Hantavirus infections for the clinician: from case presentation to diagnosis and treatment, Sargianou M, Watson DC, Chra P, Papa A, Starakis I, Gogos C, Panos G., Crit Rev Microbiol. 2012 Nov;38(4):317-29. doi: 10.3109/1040841X.2012.673553. Epub 2012 May 3. Review, PMID: 22553984 [PubMed - indexed for MEDLINE]
6. Effects of first antiretroviral regimen on lipid levels in HIV (+) individuals, Papadopoulos A, Pantazis N, Panagopoulos P, Kourkounti S, Xylomenos G, Chini M, Petrikkos G, Sambatakou H, Ioannidou P, Kordosis T, Panos G, Touloumi G., J Chemother. 2012 Feb;24(1):38-47. doi: 10.1179/1120009X12Z.0000000008, PMID: 22546723 [PubMed - indexed for MEDLINE]
7. Interleukin-12 (IL-12)/IL-10 ratio as a marker of disease severity in Crimean-Congo hemorrhagic fever, Watson DC, Sargianou M, Panos G., Clin Vaccine Immunol. 2012 May;19(5):823-4. doi: 10.1128/CVI.00030-12, PMID: 22539564 [PubMed - indexed for MEDLINE] Free PMC Article
8. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration, Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G.,Int J Epidemiol. 2012 Apr;41(2):433-45. doi: 10.1093/ije/dyr164. Epub 2011 Nov 28, PMID: 22493325 [PubMed - indexed for MEDLINE] Free Article
9. Febrile disease in a Bulgarian emigrant with acute renal failure, thrombocytopenia, bilateral subconjunctival haemorrhage and hypoxemia, Sargianou M, Watson DC, Kampiotis D, Papa A, Economopoulou A, Gogos C, Panos G., J Clin Virol. 2012 May;54(1):2-5. doi: 10.1016/j.jcv.2012.01.019. Epub 2012 Mar 3, PMID: 22386282 [PubMed - indexed for MEDLINE]
10. Dealing with the substance abuse epidemic and infective endocarditis: clinical, immunologic and pathogenetic aspects, Starakis I, Panos G, Mazokopakis E., Curr Vasc Pharmacol. 2012 Mar;10(2):247-56. Review, PMID: 22022774 [PubMed - indexed for MEDLINE]
11. Non-cirrhotic portal hypertension in HIV-infected individuals, Scourfield A, Waters L, Holmes P, Panos G, Randell P, Jackson A, Mandalia S, Gazzard B, Nelson M., Int J STD AIDS. 2011 Jun;22(6):324-8. doi: 10.1258/ijsa.2010.010396, PMID: 21680667 [PubMed - indexed for MEDLINE]
12. Pathogens and chronic or long-term neurologic disorders, Starakis I, Panos G, Koutras A, Mazokopakis EE., Cardiovasc Hematol Disord Drug Targets. 2011 Mar 1;11(1):40-52. Review, PMID: 21446901 [PubMed - indexed for MEDLINE]
13. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet, Lagadinou ED, Marangos M, Liga M, Panos G, Tzouvara E, Dimitroulia E, Tiniakou M, Tsakris A, Zoumbos N, Spyridonidis A., Transpl Infect Dis. 2010 Oct;12(5):437-40. doi: 10.1111/j.1399-3062.2010.00515.x., PMID: 20561301 [PubMed - indexed for MEDLINE]
14. Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV, Panos G, Farouk L, Stebbing J, Holmes P, Valero S, Randell P, Bower M, Gazzard B, Anderson M, Nelson M., J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):525-7. doi: 10.1097/QAI.0b013e3181bb27b1, PMID: 19901620 [PubMed - indexed for MEDLINE]
15. A meta-analysis of transient elastography for the detection of hepatic fibrosis, Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, Bower M, Gazzard B, Nelson M., J Clin Gastroenterol. 2010 Mar;44(3):214-9. doi: 10.1097/MCG.0b013e3181b4af1f., PMID: 19745758 [PubMed - indexed for MEDLINE]
16. Worldwide prevalence of head lice, Falagas ME, Matthaiou DK, Rafailidis PI, Panos G, Pappas G., Emerg Infect Dis. 2008 Sep;14(9):1493-4. doi: 10.3201/eid1409.080368. Review, PMID: 18760032 [PubMed - indexed for MEDLINE] Free PMC Article
17. Transient elastography, liver stiffness values, and acute hepatopathy., Panos G, Holmes P, Valero S, Anderson M, Gazzard B, Nelson M. Hepatology. 2008 Jun;47(6):2140; author reply 2141. doi: 10.1002/hep.22314, PMID: 18508302 [PubMed - indexed for MEDLINE]
18. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study.,  Panos G, Samonis G, Alexiou VG, Kavarnou GA, Charatsis G, Falagas ME., Curr HIV Res. 2008 May;6(3):257-60, PMID: 18473789 [PubMed - indexed for MEDLINE]
19. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials, Matthaiou DK, Panos G, Adamidi ES, Falagas ME, PLoS Negl Trop Dis. 2008 Mar 12;2(3):e194. doi: 10.1371/journal.pntd.0000194, PMID: 18335068 [PubMed - indexed for MEDLINE] Free PMC Article
20. Effect of meteorological variables on the incidence of respiratory tract infections, Falagas ME, Theocharis G, Spanos A, Vlara LA, Issaris EA, Panos G, Peppas G., Respir Med. 2008 May;102(5):733-7. doi: 10.1016/j.rmed.2007.12.010. Epub 2008 Jan 31, PMID: 18242070 [PubMed - indexed for MEDLINE]
21. Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece, Panos G, Charatsis G, Paparizos V, Kazantzi M, Falagas ME., AIDS Res Hum Retroviruses. 2008 Jan;24(1):43-51. doi: 10.1089/aid.2006.0217, PMID: 18275347 [PubMed - indexed for MEDLINE]
22. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature, Falagas ME, Zarkadoulia EA, Pliatsika PA, Panos G., Retrovirology. 2008 Feb 1;5:13. doi: 10.1186/1742-4690-5-13. Review, PMID: 18241330 [PubMed - indexed for MEDLINE] Free PMC Article
23. The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study, Smith CJ, Olsen CH, Mocroft A, Viard JP, Staszewski S, Panos G, Staub T, Blaxhult A, Vetter N, Lundgren JD, AIDS. 2008 Jan 2;22(1):47-56, PMID: 18090391 [PubMed - indexed for MEDLINE]
24. HIV-1 tropism.,Panos G, Nelson M.,  Biomark Med. 2007 Dec;1(4):473-81. doi: 10.2217/17520363.1.4.473, PMID: 20477366 [PubMed] Free Article
25. Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin, Paraskevis D, Magiorkinis E, Magiorkinis G, Sypsa V, Paparizos V, Lazanas M, Gargalianos P, Antoniadou A, Panos G, Chrysos G, Sambatakou H, Karafoulidou A, Skoutelis A, Kordossis T, Koratzanis G, Theodoridou M, Daikos GL, Nikolopoulos G, Pybus OG, Hatzakis A; Multicentre Study on HIV Heterogeneity, J Infect Dis. 2007 Oct 15;196(8):1167-76. Epub 2007 Sep 13, PMID: 17955435 [PubMed - indexed for MEDLINE] Free Article
26. Infectious disease cases for educational purposes: open-access resources on the Internet, Falagas ME, Karveli EA, Panos G., Clin Infect Dis. 2007 Aug 15;45(4):495-500. Epub 2007 Jul 10, PMID: 17638202 [PubMed - indexed for MEDLINE] Free Article
27. Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts, Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte Ad, Rakhmanova A, Phillips AN, Lundgren JD; EuroSIDA study group, Antivir Ther. 2007;12(3):325-33. Erratum in: Antivir Ther. 2007;12(4):577, PMID: 17591022 [PubMed - indexed for MEDLINE]
28. Helicobacter pylori infection in symptomatic HIV-seropositive and -seronegative patients: a case-control study, Panos GZ, Xirouchakis E, Tzias V, Charatsis G, Bliziotis IA, Doulgeroglou V, Margetis N, Falagas ME, AIDS Res Hum Retroviruses. 2007 May;23(5):709-12, PMID: 17530997 [PubMed - indexed for MEDLINE]
29. Multi-skeletal Pneumocystis jiroveci (carinii) in an HIV-seropositive patient, Panos GZ, Karydis I, Velakoulis SE, Falagas ME, Int J STD AIDS. 2007 Feb;18(2):134-7, PMID: 17331292 [PubMed - indexed for MEDLINE]
30. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation, Panos GZ, Lampropoulos KM, Angelousi AG, Charatsis GG, Falagas ME., J Clin Gastroenterol. 2007 Feb;41(2):222-3, PMID: 17245225 [PubMed - indexed for MEDLINE]
31. Impact of initial discordant treatment with beta-lactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: a systematic review, Falagas ME, Siempos II, Bliziotis IA, Panos GZ., Mayo Clin Proc. 2006 Dec;81(12):1567-74. Review, PMID: 17165635 [PubMed - indexed for MEDLINE]
32. Hyperlactatemia due to nevirapine, Panos G, Kopterides P, Falagas ME., Ann Intern Med. 2006 Dec 5;145(11):867-8, PMID: 17146078 [PubMed - indexed for MEDLINE]
33. Implications of findings of bibliometric analyses in parasitology, Falagas ME, Panos G., Trends Parasitol. 2007 Jan;23(1):12-3. Epub 2006 Nov 16, PMID: 17112782 [PubMed - indexed for MEDLINE]
34. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity, Panos G, Karveli EA, Nikolatou O, Falagas ME., Am J Hematol. 2007 Aug;82(8):761-5, PMID: 17094093 [PubMed - indexed for MEDLINE]
35. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?, Panos GZ, Betsi GI, Falagas ME., Aliment Pharmacol Ther. 2006 Sep 1;24(5):731-42. Review, PMID: 16918877 [PubMed - indexed for MEDLINE] Free Article
36. Neural network-longitudinal assessment of the Electronic Anti-Retroviral THerapy (EARTH) cohort to follow response to HIV-treatment, Hatzakis GE, Mathur M, Gilbert L, Panos G, Wanchu A, Patel AK, Maniar JK, Tsoukas CM, AMIA Annu Symp Proc. 2005:301-5, PMID: 16779050 [PubMed - indexed for MEDLINE] Free PMC Article
37. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting, Gold J, Batterham MJ, Rekers H, Harms MK, Geurts TB, Helmyr PM, Silva de Mendonça J, Falleiros Carvalho LH, Panos G, Pinchera A, Aiuti F, Lee C, Horban A, Gatell J, Phanuphak P, Prasithsirikul W, Gazzard B, Bloch M, Danner SA; E-1696 Study Investigators, HIV Med. 2006 Apr;7(3):146-55, PMID: 16494628 [PubMed - indexed for MEDLINE]
38. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece, Paraskevis D, Magiorkinis E, Katsoulidou A, Hatzitheodorou E, Antoniadou A, Papadopoulos A, Poulakou G, Paparizos V, Botsi C, Stavrianeas N, Lelekis M, Chini M, Gargalianos P, Magafas N, Lazanas M, Chryssos G, Petrikkos G, Panos G, Kordossis T, Theodoridou M, Sypsa V, Hatzakis A; Hellenic Multi-centre study on HIV-resistance, Virus Res. 2005 Sep;112(1-2):115-22. Epub 2005 Apr 8, PMID: 16022906 [PubMed- indexed for MEDLINE]
39. Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study,  Dragsted UB, Mocroft A, Vella S, Viard JP, Hansen AB, Panos G, Mercey D, Machala L, Horban A, Lundgren JD; EuroSIDA study group, J Infect Dis. 2004 Jul 1;190(1):148-55. Epub 2004 Jun 9, PMID: 15195254 [PubMed - indexed for MEDLINE] Free Article
40. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study, Florence E, Lundgren J, Dreezen C, Fisher M, Kirk O, Blaxhult A, Panos G, Katlama C, Vella S, Phillips A; EuroSIDA Study Group, HIV Med. 2003 Jul;4(3):255-62, PMID: 12859325 [PubMed - indexed for MEDLINE]
41. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study, Viard JP, Mocroft A, Chiesi A, Kirk O, Røge B, Panos G, Vetter N, Bruun JN, Johnson M, Lundgren JD; EuroSIDA Study Group, J Infect Dis. 2001 Apr 15;183(8):1290-4. Epub 2001 Mar 26, PMID: 11262215 [PubMed - indexed for MEDLINE] Free Article
42. Greek physicians' and dentists' compliance with the British society for antimicrobial chemotherapy (BSAC) guidelines for preventing bacterial endocarditis, Panos G, Giamarellou H, Papazachos G, Birbilis T, Toutouzas P., J Chemother. 1996 Aug;8(4):270-7, PMID: 8873832 [PubMed - indexed for MEDLINE]
 
Publications as investigator in national and international multicenter studies:
 
For the publications 1-54 below as investigator-
Citation Index:
Total Impact Factor (IF)= 561.916
Average Impact Factor (IF)= 10.4058
Citations (Scholar) > 3993
h-index=

1. CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use.
 Mocroft A, Phillips AN, Gatell J, Horban A, Ledergerber B, Zilmer K, Jevtovic D, Maltez F, Podlekareva D, Lundgren JD; EuroSIDA study in EuroCOORD.
 AIDS. 2013 Mar 27;27(6):907-18. doi: 10.1097/QAD.0b013e32835cb766.
 PMID: 23698060 [PubMed - in process]
 Related citations
2. Limited cross-border infections in patients newly diagnosed with HIV in Europe.
 Frentz D, Wensing AM, Albert J, Paraskevis D, Abecasis AB, Hamouda O, Jørgensen LB, Kücherer C, Struck D, Schmit JC, Åsjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, De Wit S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher CA, Van de Vijver DA; SPREAD Programme.
 Retrovirology. 2013 Apr 3;10:36. doi: 10.1186/1742-4690-10-36.
 PMID: 23551870 [PubMed - in process] Free PMC Article
 Related citations
3. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
 Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM; INSIGHT SMART Study Group.
 PLoS One. 2013;8(2):e56249. doi: 10.1371/journal.pone.0056249. Epub 2013 Feb 15.
 PMID: 23457535 [PubMed - in process] Free PMC Article
 Related citations
4. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
 Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group.
 J Infect Dis. 2013 May 1;207(9):1359-69. doi: 10.1093/infdis/jit043. Epub 2013 Feb 4.
 PMID: 23382571 [PubMed - indexed for MEDLINE]
 Related citations
5. Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
 May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).
 Int J Epidemiol. 2012 Dec;41(6):1807-20. doi: 10.1093/ije/dys164. Epub 2012 Nov 12.
 PMID: 23148105 [PubMed - indexed for MEDLINE]
 Related citations
6. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
 Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M, Reiss P, El-Sadr W, Monforte AD, Friis-Møller N, Lundgren JD, Law MG; D:A:D Study Group.
 J Int AIDS Soc. 2012 Oct 10;15(2):17426. doi: 10.7448/IAS.15.2.17426.
 PMID: 23078769 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
7. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.
 Theys K, Deforche K, Vercauteren J, Libin P, van de Vijver DA, Albert J, Asjö B, Balotta C, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Hamouda O, Horban A, Korn K, Kostrikis LG, Kücherer C, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stockl E, Riva C, Ruiz L, Liitsola K, Schmit JC, Schuurman R, Sönnerborg A, Stanekova D, Stanojevic M, Struck D, Van Laethem K, Wensing AM, Boucher CA, Vandamme AM; SPREAD-programme.
 Retrovirology. 2012 Oct 3;9:81. doi: 10.1186/1742-4690-9-81.
 PMID: 23031662 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
8. Platelet count kinetics following interruption of antiretroviral treatment.
 Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD; INSIGHT SMART Study Group.
 AIDS. 2013 Jan 2;27(1):59-68. doi: 10.1097/QAD.0b013e32835a104d.
 PMID: 23018440 [PubMed - indexed for MEDLINE]
 Related citations
9. The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression.
 Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A, Gatell J, Fisher M, Trocha H, Rakhmanova A, Lundgren JD; EuroSIDA Study in EuroCOORD.
 Antivir Ther. 2012;17(7):1291-300. doi: 10.3851/IMP2407. Epub 2012 Sep 26.
 PMID: 23013779 [PubMed - indexed for MEDLINE]
 Related citations
10. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study.
 Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A, Horban A, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord.
 PLoS One. 2012;7(7):e41673. doi: 10.1371/journal.pone.0041673. Epub 2012 Jul 23.
 PMID: 22911841 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
11. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
 Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, Grzeszczuk A, Sambatakou H, Mocroft A, Kirk O; EuroSIDA in EuroCoord.
 AIDS. 2012 Sep 24;26(15):1917-26.
 PMID: 22781222 [PubMed - indexed for MEDLINE]
 Related citations
12. The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
 HIV-CAUSAL Collaboration.
 AIDS. 2012 Aug 24;26(13):1691-705.
 PMID: 22546987 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
13. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
 HIV-CAUSAL Collaboration.
 Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28.
 PMID: 22460971 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
14. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy.
 Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, Gatell J, d'Arminio Monforte A, Phillips A, Lundgren JD, Kirk O; EuroSIDA study group.
 AIDS. 2012 Jan 28;26(3):315-23. doi: 10.1097/QAD.0b013e32834e8805.
 PMID: 22112597 [PubMed - indexed for MEDLINE]
 Related citations
15. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata.
 Reekie J, Gatell JM, Yust I, Bakowska E, Rakhmanova A, Losso M, Krasnov M, Francioli P, Kowalska JD, Mocroft A; EuroSIDA in EuroCoord.
 AIDS. 2011 Nov 28;25(18):2259-68. doi: 10.1097/QAD.0b013e32834cdb4b.
 PMID: 21918422 [PubMed - indexed for MEDLINE]
 Related citations
16. A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy.
 Paredes R, Puertas MC, Bannister W, Kisic M, Cozzi-Lepri A, Pou C, Bellido R, Betancor G, Bogner J, Gargalianos P, Bánhegyi D, Clotet B, Lundgren J, Menéndez-Arias L, Martinez-Picado J; EuroSIDA Study Group.
 J Infect Dis. 2011 Sep 1;204(5):741-52. doi: 10.1093/infdis/jir385.
 PMID: 21844300 [PubMed - indexed for MEDLINE] Free Article
 Related citations
17. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.
 Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, Domingo P, Mocroft A, Lundgren JD, Kirk O; EuroSIDA study group.
 AIDS. 2011 Jul 31;25(12):1505-13. doi: 10.1097/QAD.0b013e328348fafd.
 PMID: 21610489 [PubMed - indexed for MEDLINE]
 Related citations
18. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.
 Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M, Gatell J, Pedersen C, Bogner JR, Lundgren JD, Mocroft A; EuroSIDA Study Group.
 AIDS. 2011 Jun 19;25(10):1305-15. doi: 10.1097/QAD.0b013e328347f6f7.
 PMID: 21522006 [PubMed - indexed for MEDLINE]
 
19. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.
 Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J, Sambatakou H, Pedersen C, Lundgren JD, Kirk O; Eurosida Study Group.
 HIV Clin Trials. 2011 Mar-Apr;12(2):109-17. doi: 10.1310/hct1202-109.
 PMID: 21498154 [PubMed - indexed for MEDLINE]
 Related citations
20. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.
 Bannister WP, Cozzi-Lepri A, Kjær J, Clotet B, Lazzarin A, Viard JP, Kronborg G, Duiculescu D, Beniowski M, Machala L, Phillips A; EuroSIDA group.
 J Antimicrob Chemother. 2011 Apr;66(4):901-11. doi: 10.1093/jac/dkr006. Epub 2011 Jan 31.
 PMID: 21393179 [PubMed - indexed for MEDLINE] Free Article
 Related citations
21. A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.
 Reekie J, Reiss P, Ledergerber B, Sedlacek D, Parczewski M, Gatell J, Katlama C, Fätkenheuer G, Lundgren JD, Mocroft A; EuroSIDA study group.
 HIV Med. 2011 May;12(5):259-68. doi: 10.1111/j.1468-1293.2010.00877.x. Epub 2010 Aug 31.
 PMID: 20812948 [PubMed - indexed for MEDLINE]
 Related citations
22. Dialysis and renal transplantation in HIV-infected patients: a European survey.
 Trullas JC, Mocroft A, Cofan F, Tourret J, Moreno A, Bagnis CI, Fux CA, Katlama C, Reiss P, Lundgren J, Gatell JM, Kirk O, Miró JM; EuroSIDA Investigators.
 J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):582-9. doi: 10.1097/QAI.0b013e3181efbe59.
 PMID: 20811290 [PubMed - indexed for MEDLINE]
 Related citations
23. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.
 Mocroft A, Reiss P, Gasiorowski J, Ledergerber B, Kowalska J, Chiesi A, Gatell J, Rakhmanova A, Johnson M, Kirk O, Lundgren J; EuroSIDA Study Group.
 J Acquir Immune Defic Syndr. 2010 Oct;55(2):262-70. doi: 10.1097/QAI.0b013e3181e9be6b.
 PMID: 20700060 [PubMed - indexed for MEDLINE]
 Related citations
24. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.
 Reekie J, Kosa C, Engsig F, Monforte Ad, Wiercinska-Drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, Lundgren JD, Mocroft A; EuroSIDA Study Group.
 Cancer. 2010 Nov 15;116(22):5306-15. doi: 10.1002/cncr.25311.
 PMID: 20661911 [PubMed - indexed for MEDLINE] Free Article
 Related citations
25. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
 Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN.
 Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15.
 PMID: 20638118 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
26. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
 Friis-Møller N, Thiébaut R, Reiss P, Weber R, Monforte AD, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG; DAD study group.
 Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):491-501. doi: 10.1097/HJR.0b013e328336a150.
 PMID: 20543702 [PubMed - indexed for MEDLINE]
 Related citations
27. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
 Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD; EuroSIDA Study Group.
 AIDS. 2010 Jul 17;24(11):1667-78. doi: 10.1097/QAD.0b013e328339fe53.
 PMID: 20523203 [PubMed - indexed for MEDLINE]
 Related citations
28. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.
 Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van Lunzen J, Chiesi A, Pradier C, Machala L, Lundgren JD; EuroSIDA Study Group.
 HIV Med. 2010 Aug;11(7):469-78. doi: 10.1111/j.1468-1293.2009.00816.x. Epub 2010 Feb 22.
 PMID: 20201975 [PubMed - indexed for MEDLINE]
 Related citations
29. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
 Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte Ad, Flisiak R, Lundgren J; EuroSIDA.
 J Antimicrob Chemother. 2010 Mar;65(3):548-55. doi: 10.1093/jac/dkp479. Epub 2010 Jan 5.
 PMID: 20051475 [PubMed - indexed for MEDLINE] Free Article
 Related citations
30. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.
 Worm SW, Friis-Møller N, Bruyand M, D'Arminio Monforte A, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C; D:A:D study group.
 AIDS. 2010 Jan 28;24(3):427-35. doi: 10.1097/QAD.0b013e328334344e.
 PMID: 19910787 [PubMed - indexed for MEDLINE]
 Related citations
31. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
 Rodger AJ, Fox Z, Lundgren JD, Kuller LH, Boesecke C, Gey D, Skoutelis A, Goetz MB, Phillips AN; INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group.
 J Infect Dis. 2009 Sep 15;200(6):973-83. doi: 10.1086/605447.
 PMID: 19678756 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
32. Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.
 Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte Ad, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD; EuroSIDA Study Group.
 J Infect Dis. 2009 Sep 1;200(5):687-97. doi: 10.1086/604731.
 PMID: 19604043 [PubMed - indexed for MEDLINE] Free Article
 Related citations
33. Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.
 Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration.
 AIDS. 2009 Aug 24;23(13):1689-99. doi: 10.1097/QAD.0b013e32832d3b54.
 PMID: 19487907 [PubMed - indexed for MEDLINE]
 Related citations
34. Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.
 Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Ledergerber B, Lundgren JD; EuroSIDA Study Group.
 J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):457-63.
 PMID: 19360931 [PubMed - indexed for MEDLINE]
 Related citations
35. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
 Antiretroviral Therapy Cohort Collaboration (ART-CC), Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C, Fatkenheuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R, Saag M.
 Clin Infect Dis. 2009 Apr 15;48(8):1138-51. doi: 10.1086/597468.
 PMID: 19275498 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
36. Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
 Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group.
 AIDS. 2009 Jan 2;23(1):71-82. doi: 10.1097/QAD.0b013e32831cc129.
 PMID: 19050388 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
37. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?
 Antiretroviral Therapy Cohort Collaboration (ART-CC), Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M, Phillips A, Günthard HF, Dabis F, Hogg R, de Wolf F, Fatkenheuer G, Gill MJ, Justice A, D'Arminio Monforte A, Lampe F, Miró JM, Staszewski S, Sterne JA.
 AIDS. 2008 Nov 30;22(18):2481-92. doi: 10.1097/QAD.0b013e328318f130.
 PMID: 19005271 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
38. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
 Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, Clumeck N, Kirk O, Gazzard B, Lundgren JD; EuroSIDA Study Group.
 AIDS. 2008 Nov 12;22(17):2381-90. doi: 10.1097/QAD.0b013e328317a6eb.
 PMID: 18981778 [PubMed - indexed for MEDLINE]
 Related citations
39. Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.
 Fox Z, Phillips A, Cohen C, Neuhaus J, Baxter J, Emery S, Hirschel B, Hullsiek KH, Stephan C, Lundgren J; SMART Study Group.
 AIDS. 2008 Nov 12;22(17):2279-89. doi: 10.1097/QAD.0b013e328311d16f.
 PMID: 18981767 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
40. The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.
 Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, Kirk O; EuroSIDA Study Group.
 Cent Eur J Public Health. 2008 Sep;16(3):99-105. Review.
 PMID: 18935770 [PubMed - indexed for MEDLINE]
 Related citations
41. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
 Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.
 AIDS. 2008 Oct 18;22(16):2187-98. doi: 10.1097/QAD.0b013e328310e04f.
 PMID: 18832882 [PubMed - indexed for MEDLINE]
 Related citations
42. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
 Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.
 AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77.
 PMID: 18832878 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
43. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
 Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.
 J Infect Dis. 2008 Nov 1;198(9):1337-44. doi: 10.1086/592171.
 PMID: 18767985 [PubMed - indexed for MEDLINE] Free Article
 Related citations
44. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
 SMART Study Group, El-Sadr WM, Grund B, Neuhaus J, Babiker A, Cohen CJ, Darbyshire J, Emery S, Lundgren JD, Phillips A, Neaton JD.
 Ann Intern Med. 2008 Sep 2;149(5):289-99.
 PMID: 18765698 [PubMed - indexed for MEDLINE]
 Related citations
45. Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.
 Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD; Eurosida Study Group.
 Scand J Infect Dis. 2008;40(11-12):908-13. doi: 10.1080/00365540802227094.
 PMID: 18609197 [PubMed - indexed for MEDLINE]
 Related citations
46. Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
 Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD; EuroSIDA study group.
 J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):324-33. doi: 10.1097/QAI.0b013e31817ae5c0.
 PMID: 18545152 [PubMed - indexed for MEDLINE]
 Related citations
47. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
 Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN.
 J Infect Dis. 2008 Apr 15;197(8):1145-55. doi: 10.1086/529523.
 PMID: 18476293 [PubMed - indexed for MEDLINE] Free Article
 Related citations
48. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.
 Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R.
 J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713.
 PMID: 18476292 [PubMed - indexed for MEDLINE] Free Article
 Related citations
49. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.
 Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.
 Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.
 PMID: 18461712 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
50. Loss to follow-up in an international, multicentre observational study.
 Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, Vetter N, Dabis F, Gatell J, Lundgren JD; EuroSIDA study group.
 HIV Med. 2008 May;9(5):261-9. doi: 10.1111/j.1468-1293.2008.00557.x.
 PMID: 18400074 [PubMed - indexed for MEDLINE]
 Related citations
51. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.
 D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.
 Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292.
 PMID: 18387667 [PubMed - indexed for MEDLINE] Free PMC Article
 Related citations
52. CD4+ count-guided interruption of antiretroviral treatment.
Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fätkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C.
N Engl J Med 2006 Nov 30;355(22):2283-96.
53. HIV Med. 2004 Nov;5(6):437-47.
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.
Mocroft A, Monforte Ad, Kirk O, Johnson MA, Friis-Moller N, Banhegyi D, Blaxhult A, Mulcahy F, Gatell JM,Lundgren JD; EuroSIDA study group.
54. Combination antiretroviral therapy and the risk of myocardial infarction.
Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group.
N Engl J Med 2003 Nov 20;349(21):1993-2003.

Επιλεγμένες Ομιλίες

1. Στρογγυλό Τραπέζι:
"Ασυνήθεις καταστάσεις και εκδηλώσεις της HIV λοίμωξης"
Η συνύπαρξη σπλαχνικής λεισμανιάσεως και βρουκελώσεως – Αφορμή για τη διάγνωση της HIV λοίμωξης
Εισηγητής: Γ. Πάνος
5ο Πανελλήνιο Συνέδριο AIDS, Αθήνα, 1993.
2. Στρογγυλό Τραπέζι:
"Αντιρετροική αγωγή και θεραπεία καιροσκοπικών λοιμώξεων"
Φυματίωση
Εισηγητής: Γ. Πάνος
6ο Πανελλήνιο Συνέδριο AIDS, Θεσσαλονίκη 1994.
3. Στρογγυλό Τραπέζι:
"Επιδημιολογία του AIDS"
Προγράμματα πρόληψης HIV λοίμωξης παγκοσμίως
Εισηγητής: Γ. Πάνος
13ο Πανελλήνιο Συνέδριο AIDS, Αθήνα 2001.
4. Interactive Συμπόσιο
Στρατηγική και προβλήματα αντιρετροικής αγωγής
Εισηγητής: Γ. Πάνος
11ο Πανελλήνιο Συνέδριο AIDS, Αθήνα 1999.
5. Στρογγυλό Τραπέζι:
"Η Επιδημία του AIDS σήμερα"
Επιδημιολογία
Εισηγητής: Γ. Πάνος
Διήμερο Επιστημονικό Συμπόσιο “AIDS”, ΚΕΕΛ /Ε ιατρικά, Νοέμβριος 2002.
6. Στρογγυλό τραπέζι:
Κλινικό φροντιστήριο καθηγητών δευτεροβάθμιας εκπαίδευσης.
Πρόεδροι: Γ. Πάνος - Θ. Δαρδαβέσης
16ο Πανελλήνιο Συνέδριο ΑΙDS
Αθήνα, 11/11/2004
7. Στρογγυλό τραπέζι:
Κλινικό φροντιστήριο καθηγητών δευτεροβάθμιας εκπαίδευσης.
Φυσική πορεία της HIV λοίμωξης: Γ. Πάνος
16ο Πανελλήνιο Συνέδριο ΑΙDS
Αθήνα, 11/11/2004
8. Στρογγυλό Τραπέζι: Λοιμώξεις σε αιματολογικούς ασθενείς.
Συζήτηση περιστατικών. Διαδραστική συνεδρία.
Προεδρείο: Κωνσταντίνος Τσαταλάς, Μαρία Παπαιωάννου
Ιογενείς Λοιμώξεις: Αλέξανδρος Σπυριδωνίδης – Γεώργιος Πάνος
ΗΜΕΡΙΔΑ 2008, Τμήμα Οξείων Λευχαιμιών και Υπερπλαστικών Συνδρόμων και Τμήμα Παιδιατρικής Αιματολογίας, Καμένα Βούρλα, Ξενοδοχείο Galini Wellness Spa & Resort, 11 Οκτωβρίου 2008.
9. Στρογγυλό Τραπέζι: Καιροσκοπικές Λοιμώξεις το 2008 και Συλλοιμώξεις – Σύγχρονη Προσέγγιση (28/11/2008)
Ηπατίτιδες: Γ. Πάνος
20ο Πανελλήνιο Συνέδριο AIDS, Ελληνική Εταιρεία Μελέτης και Αντιμετώπισης του AIDS,
Ξενοδοχείο Grande Bretagne, 28-30 Νοεμβρίου 2008.
10. Στρογγυλό Τραπέζι «Εμβόλια»
Προεδρείο: Κ. Σπυρόπουλος, Π. Θεοδωρόπουλος
Ομιλητής: Γ. Πάνος
Εμβόλια σε ταξιδιώτες
2ο Συνέδριο του Τμήματος Λοιμώξεων της Παθολογικής Κλινικής του Ιατρικού Τμήματος Πανεπιστημίου Πατρών, Συνεδριακό Κέντρο Πανεπιστημίου Πατρών, Εξελίξεις στα λοιμώδη νοσήματα, 20-22 Φεβρουαρίου 2009.
11. Στρογγυλό Τραπέζι: Λοιμώξεις Αναπνευστικού
Ομιλητής: Γ. Πάνος
«Αρχές ομοφωνίας στην διάγνωση και θεραπεία της ενδονοσοκομειακής πνευμονίας»
12ο Εκπαιδευτικό Σεμινάριο Πνευμονολογικής Κλινικής ΠΓΝΠ, Συνεδριακό Πολιτιστικό Κέντρο Πανεπιστημίου Πατρών, 26-28 Μαρτίου, 2009.
12. Στρογγυλό Τραπέζι: Λοιμώξεις
Ομιλητής: Γ. Πάνος
«Λοιμώξεις Χειρουργικού τραύματος»
Αγγειοχειρουργική Διημερίδα – Αχαικές Χειρουργικές Ημέρες, Συνεδριακό Πολιτιστικό Κέντρο Πανεπιστημίου Πατρών, 24 Απριλίου 2009
13. Στρογγυλό Τραπέζι
Ομιλητής: Γ. Πάνος
«Ο ρόλος των αντιβιοτικών στις σηπτικές ψευδαρθρώσεις»
3ο Πανελλήνιο Συνέδριο Διατατικής Ιστογένεσης, Ορθοπαιδική Κλινική Πανεπιστημίου Πατρών, Συνεδριακό Κέντρο  Πανεπιστημίου Πατρών, 18 Σεπτεμβρίου, 2009.
14. Στρογγυλό Τραπέζι  "Παθογένεια της HIV Λοίμωξης"
Ομιλητής: Γ. Πάνος
Είσοδος του HIV στα κύτταρα στόχος: Πώς επιτυγχάνεται; (HIV entry)
21ο Πανελλήνιο Συνέδριο AIDS, Ελληνική Εταιρεία Μελέτης και Αντιμετώπισης του AIDS,
Ξενοδοχείο Hyatt, Θεσσαλονίκη, 20-22 Νοεμβρίου 2009.
15. Στρογγυλό Τραπέζι: «Νοσήματα που προλαμβάνονται με εμβολιασμούς-2»
Ομιλητής: Γ. Πάνος
Εισήγηση: "Ιαπωνική εγκεφαλίτιδα και εγκεφαλίτιδα κεντρικής Ευρώπης"
2ο Νοσηλευτικό Σχολείο Λοιμώξεων, Ξενοδοχείο Divani Caravel, Αθήνα, 10 Οκτωβρίου, 2009.
16. Στρογγυλό Τραπέζι «Λοιμώξεις από άτυπα μυκοβακτηρίδια»
Ομιλητής: Γ. Πάνος
"Θεραπεία"
3ο Συνέδριο του Τμήματος Λοιμώξεων της Παθολογικής Κλινικής του Ιατρικού Τμήματος Πανεπιστημίου Πατρών, Συνεδριακό Κέντρο Πανεπιστημίου Πατρών, Εξελίξεις στα λοιμώδη νοσήματα, 26-28 Φεβρουαρίου 2010.
17. Στρογγυλό Τραπέζι «Λοιμώξεις Αναπνευστικού»
Ομιλητής: Γ. Πάνος
«Ο ρόλος των αντιβιοτικών στη θεραπεία της παρόξυνσης ΧΑΠ»
13ο Εκπαιδευτικό Σεμινάριο της Πνευμονολογικής Κλινικής του ΠΓΝΠ Πατρών, Συνεδριακό Κέντρο Πανεπιστημίου Πατρών, 5 Ιουνίου, 2010.
18. Στρογγυλό Τραπέζι «Λοιμώξεις και Πεπτικό Σύστημα»
Ομιλητής: Γ. Πάνος
"Παρασιτικές λοιμώξεις στο πεπτικό στην Ελλάδα σήμερα"
5η Ετήσια Εκπαιδευτική Γαστρεντερολογική Διημερίδα. «Νεότερες εξελίξεις στη Γαστρεντερολογία». Γαστρεντερολογική Κλινική Πανεπιστημίου Πατρών, Ελληνική Γαστρεντερολογική Εταιρεία, Ξενοδοχείο Olympian Village Aldemar, Σκαφιδια, Ηλείας, 11 Ιουνίου, 2010.
19. Στρογγυλό Τραπέζι «Πνευμονολογικά Θέματα»
Ομιλητής: Γ. Πάνος
«Πνευμονία στην κοινότητα»
2ο Θερινό Σχολείο Γηριατρικής, Γηριατρική Γεροντολογική Εταιρεία Νοτιοδυτικής Ελλάδος, Hinitsa Bay Hotel, Πόρτο Χέλι, 17-20 Ιουνίου 2010.
20. Στρογγυλό Τραπέζι «Ενδιαφέροντα Παθογόνα»
Ομιλητής: Γ. Πάνος
"Πρωτολοίμωξη με HIV"
6ος Δεκάλογος για τις λοιμώξεις. Τι νεότερο το 2010.
Ξενοδοχείο Hilton, Αθήνα, 20 Νοεμβρίου, 2010.
21. Στρογγυλό Τραπέζι «Αντιμετώπιση κοινών λοιμώξεων της κοινότητας»
Ομιλητής: Γ. Πάνος
"Ουροποιητικού"
1ο Παμπελοποννησιακό Συμπόσιο Γενικής Ιατρικής, ΕΛΕΓΕΙΑ, Συνεδριακό και Πολιτιστικό Κέντρο Πανεπιστημίου Πατρών, Πάτρα, 5 Δεκεμβρίου, 2010.
2011
22. 1ο Πανελλήνιο Συνέδριο Βορείου Ελλάδος
"Σύγχρονες Εξελίξεις της Λοιμωξιολογίας"
Στρογγυλό Τραπέζι: "Η πνευμονιοκοκκική νόσος σήμερα"
Εισηγητής: Γ. Πάνος
Η θέση του νέου αντιπνευμονιοκοκκικού εμβολίου
Ξενοδοχείο HYATT, 9-11 Δεκεμβρίου, 2011, Θεσσαλονίκη
2012
23. 12ο Πανελλήνιο Συνέδριο της Ελληνικής Εταιρίας Λοιμώξεων
Στρογγυλό Τραπέζι "Αναδυόμενες και επανεμφανιζόμενες λοιμώξεις στην Ελλάδα"
Εισηγητής: Γ. Πανος
"Λέπρα"
Ξενοδοχείο Divani Caravel, Αθήνα 3-5 Φεβρουαρίου 2012

Επίβλεψη Διδακτορικών Διατριβών

As Supervisor
I. PhD Research (carried out by supervised candidates)
(1)  HCV/Fibrosis/Biomarkers/Antiviral treatment
(2)  Hospital Infections Surveillance and Control utilizing real time web based record of pertinent patient, microbiology, pharmacy(DDDs), prevention measures
(3)  Pneumonia treated in Hospital (community and Hospital acquired). Clinical and Laboratory parameters to predict severity, treatment duration; utilization of biomarkers.
(4) Brucellosis and brucellosis osteomyelitis; recurrency, treatment regimens and treatment duration. Utilisation of clinical and laboratory/serology parameters, and biomarkers.
(5) HIV – basic science and immunology – planning stage; candidate to collaborate with National Cancer Institute (NCI)
II. MSc Research
(1)  HIV: CD4, VL and ART treatment regimens for 678 patients followed; mathematical parameters that indicate treatment success or failure.
(2)  Crimean Congo hemorrhagic fever and Hantaan virus infection: seroprevalence and risk factors among humans in Achaia, Western Greece.
(3)  Mouth wash as a method to diagnose by PCR method, HPV infection of the oral cavity in HIV seropositive persons.

Άλλες Δραστηριότητες

• As Principal Investigator
(1) Research program  collaborating with Computer/Software Engineers  of Patras University to create an electronic medical record with a target to facilitate differential diagnosis
(2) Evolving an HIV real time web based medical record facilitating laboratory parameter record and graph depiction, sequential treatment record and cost.
 
• Διδασκαλία του μαθήματος "Εισαγωγή στην Παθολογία και Επείγουσα Ιατρική", στο Τμήμα Φαρμακευτικής του Πανεπιστημίου Πατρών, Σχολή Επιστημών Υγείας.

• Συντήρηση και Παρουσίαση Ιστοσελίδας www.hivaids.gr που απευθύνεται στον γενικό πληθυσμό σε HIV οροθετικά άτομα και επαγγελματίες υγείας